PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
n-hexane bark extract of O. echioides root demonstrated therapeutic effects in vivo against Streptozotocin-induced diabetic neuropathy in SD rats [PMID:31099436]; it also decreased ROS levels and apoptosis in human neuroblastoma cell lines [PMID:29629826].
A dimer of alkannin/shikonin isolated from the root bark promoted the wound-healing process in excision and incision wound models in albino rats [PMID:25572039].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30522376 (2020) — Evaluation of Noxious Consequence of Bark Extract of Onosma echioides Linn Root: Hematology, Biochemistry, and Histopathological Findings. · Journal of dietary supplements
- 2.PMID: 31099436 (2019) — Beneficial effects of n-hexane bark extract of Onosma echioides L. on diabetic peripheral neuropathy. · Journal of cellular biochemistry
- 3.PMID: 18327849 (2008) — Alkannin/shikonin mixture from roots of Onosma echioides (L.) L.: extraction method study and quantification. · Journal of separation science
- 4.PMID: 29629826 (2019) — Cure of human diabetic neuropathy by HPLC validated bark extract of Onosma echioides L. root. · Natural product research
- 5.PMID: 25572039 (2015)